NasdaqGS:LFSTHealthcare
LifeStance Health Group (LFST) Could Be 13% Undervalued On Its Q1 Earnings Beat
Q1 earnings beat sets the stage for closer scrutiny
LifeStance Health Group (LFST) recently reported Q1 revenue of $403.5 million, up 21.2% year on year, exceeding analyst expectations by 4.2% and giving investors fresh numbers to reassess the stock.
The quarter also brought net income growth of $13.5 million and a 48% increase in Adjusted EBITDA. At the same time, LifeStance Health offered the weakest guidance update among its peers, which may temper sentiment despite the strong headline...